Mostrar el registro sencillo del ítem
Ribavirin was beneficial for patients with SARS and MERS: uncertain if it is effective for patients with COVID-19
dc.contributor.author | Allen, Claire | |
dc.date.accessioned | 2020-04-25T00:58:07Z | |
dc.date.available | 2020-04-25T00:58:07Z | |
dc.date.issued | 2020-03-20 | |
dc.identifier.uri | https://www.evidenceaid.org/ribavarin-was-beneficial-for-patients-with-sars-and-mers-uncertain-if-it-is-effective-for-patients-with-covid-19/ | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/1215 | |
dc.description.abstract | Citation: Luo T, Na Y, Tan L, et al. The Possibility of Ribavirin in the Treatment of the Coronavirus Disease 2019: A Systematic Review. China Pharmaceuticals 2020; 29(5): 34-9 Language: Chinese What is this? Like COVID-19, severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) are acute respiratory diseases caused by a coronavirus. Ribavirin was used to treat patients with these earlier coronaviruses and might be considered as a treatment for COVID-19. In this systematic review, the authors searched Chinese and English literature databases for research of any design testing ribavirin as a treatment of SARS or MERS. They did their search in February 2020. They identified 8 retrospective cohort studies, 8 case reports and 2 systematic reviews. Nine of these were for SARS 9 were for MERS. What works: Nothing noted. What doesn’t work: Nothing noted. What’s uncertain: Although ribavirin was beneficial for SARS and MERS, it is uncertain if it will be an effective treatment for patients with COVID-19. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Infectious Diseases | en_US |
dc.subject | Severe Acute Respiratory Syndrome (SARS) | en_US |
dc.subject | Middle East Respiratory Syndrome (MERS) | en_US |
dc.subject | Ribavirin | en_US |
dc.title | Ribavirin was beneficial for patients with SARS and MERS: uncertain if it is effective for patients with COVID-19 | en_US |
eihealth.country | Global (WHO/OMS) | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.category | Candidate therapeutics RD | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | Evidence Aid | en_US |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |